StreetInsider.com  Sep 23  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioSante+Pharmaceuticals+%28BPAX%29+and+Cell+Genesys+%28CEGE%29+Announce+Final+Exchange+Ratio+for+Merger/4964402.html for the full story.
FierceBiotech  Aug 10  Comment 
BioSante Pharmaceuticals says that its planned merger with Cell Genesys will bring in between $20 million and $25 million, which can fund its development program for a gel to treat female sexual dysfunction. LibiGel is now in Phase III trials and...
Bloomberg  Aug 7  Comment 
(Update2) BioSante Pharmaceuticals Inc., the developer of a gel to treat female sexual dysfunction, aims to fund clinical trials with cash from its planned acquisition of Cell Genesys Inc., a developer of cancer vaccines.
Globe Newswire  Jun 30  Comment 
BALA CYNWYD, Pa., June 30, 2009 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cell Genesys, Inc. ("Cell Genesys" or the "Company") (Nasdaq:CEGE) related to
Wall Street Journal  Jun 30  Comment 
BioSante Pharmaceuticals agreed to acquire Cell Genesys for $38 million in stock, with the combined company expected to focus on female-sexual dysfunction and immunotherapy drugs.
StreetInsider.com  Jun 23  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cell+Genesys+%28CEGE%29+Reports+Tender+Offer+Results%2C+Continues+to+Pursue+Strategic+Alternatives/4748442.html for the full story.

You may also be interested in articles related to Cell Genesys (CEGE):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki